Category Archives: Clinical Trials

New Study: How Much Increased Cancer Risk As a Carrier of Breast Cancer Genes?

Posted on June 20, 2017 by Dr. Jay Harness Staff

Women who carry genetic mutations in the “breast cancer genes,” called BRCA1 and BRCA2, have about a 70 percent chance of developing breast cancer in their lifetimes, according to a new study published in the journal JAMA, as reported in … Continue reading →

Posted in Clinical Trials, Dr. Jay Harness Expertise, Genetic Screening & Testing, Information Strength, Prevention, Research News, Video, We Live You®: The Latest | Tagged , , | Comments Off

To Avoid ‘Financial Toxicity’, Working to Lessen the High Cost of Cancer Care

Posted on June 12, 2017 by Dr. Jay Harness Staff

A group of prominent cancer doctors is planning a novel assault on high drug costs, using clinical trials to show that many oncology medications could be taken at lower doses or for shorter periods without hurting their effectiveness, in this … Continue reading →

Posted in Chemotherapy, Clinical Trials, Doctor-Patient Relationship, Information Strength, Research News, We Live You®: The Latest | Tagged , , , | Comments Off

Cancer Drug Proves to Be Effective Against Multiple Tumors Based on Genetics, Rather Than Body Location

Posted on June 9, 2017 by Dr. Jay Harness Staff

How do we treat advanced cancers that have resisted every standard treatment? This report in the New York Times discusses an answer that already carries promise. In a trial of 86 cancer patients, with tumors of the pancreas, prostate, uterus … Continue reading →

Posted in Clinical Trials, Emotional Reconstruction®, Genetic Screening & Testing, Information Strength, Research News, We Live You®: The Latest | Tagged , | Comments Off

CRISPR Gene-Editing Technology May Not Be Nearly as Precise as Previously Thought

Posted on June 1, 2017 by Dr. Jay Harness Staff

One month ago we discussed how the CRISPR genome-editing tool offers promise in cancer immunotherapy. The revolutionary gene-editing technology CRISPR-Cas9 is often described as “molecular scissors” for its ability to turn previously improbable feats of genetic engineering into exercises in … Continue reading →

Posted in Clinical Trials, Genetic Screening & Testing, Information Strength, Research News, We Live You®: The Latest | Tagged , , , , | Comments Off

FDA Approves First Drug to Target Genetic Traits Of Cancer, Rather Than Body Location

Posted on May 26, 2017 by Dr. Jay Harness Staff

The US Food & Drug Administration approved the first ever cancer drug that treats specific genetic traits of the disease, rather than the part of the body in which the cancerous tumor is located, as reported by the Los Angeles … Continue reading →

Posted in Clinical Trials, Genetic Screening & Testing, Information Strength, Research News, We Live You®: The Latest | Tagged , , , , | Comments Off

DCIS/Stage 0: Pre-Cancer, Breast Cancer or Risk Factor, Requiring Aggressive Treatment or Active Surveillance?

Posted on May 1, 2017 by Dr. Jay Harness Staff

A diagnosis of abnormal cells in a breast, or Stage 0 breast cancer, as it’s sometimes labeled, raises vexing questions for the 60,000 women a year diagnosed in the United States with ductal carcinoma in situ [DCIS], a condition in … Continue reading →

Posted in Clinical Trials, Early Detection, Information Strength, Research News, We Live You®: The Latest | Tagged , , , | Comments Off

China Scientists Testing Gene Editing CRISPR Technique in Quest to Cure Cancer

Posted on April 28, 2017 by Dr. Jay Harness Staff

On Friday, a team of Chinese scientists used the cutting-edge gene editing technique CRISPR-Cas9 on humans for the second time in history, injecting a cancer patient with modified human genes in hopes of vanquishing the disease, in this report from … Continue reading →

Posted in Clinical Trials, Genetic Screening & Testing, Information Strength, International Authority, Research News, We Live You®: The Latest | Tagged , , | Comments Off

New Cancer Therapy Shows Promise in Treating Aggressive Solid Tumors

Posted on December 31, 2016 by Dr. Jay Harness Staff

Offering hope for the New Year comes this story. A new cancer treatment called CAR-T cell immunotherapy has for the first time been found to work in a solid tumor cancers, offering hope this technique could be used to target … Continue reading →

Posted in Clinical Trials, Information Strength, Research News, We Live You®: The Latest | Tagged , , | Comments Off